News Archive

Washington, D.C. – Edgeworth Economics has prepared a report titled “Dangers of the Game” for the NFL Players Association, analyzing player injuries in the 2010 regular season. This report was recently featured in a cover story on Esquire.com. Edgeworth found substantial increases in injury frequency and severity in the 2010 season.

Edgeworth President John H. Johnson and Senior Vice President Jesse David, along with economist Paul Torelli, discuss the unique circumstances surrounding antitrust cases that target labor markets.

Washington, D.C. - At the request of the NFL Players Association, Edgeworth Economics undertook a study of the economic impact of a potential lockout in 2011. Edgeworth’s analysis is based on publicly available data from NFL teams, stadium managers/owners, and other public agencies.

Washington, D.C. - In the most recent issue of the ABA’s Antitrust Practitioner, Edgeworth experts Dr. John Johnson, Mr. Boris Vabson, and Mr. Matthew Milner discuss the impact of the Third Circuit’s In re Hydrogen Peroxide decision on ongoing as well as prospective class certification proceedings.

Dr. Jesse David conducted a seminar at Arnold & Porter in Los Angeles. Dr. David’s talk covered an increasingly common form of litigation – antitrust counterclaims against a patent holder suing for infringement.

Washington, D.C. - Edgeworth Economics is pleased to announce that Dr. John Johnson has been appointed an Assistant Editor of the Antitrust Law Journal for the 2010-2011 ABA year.

Washington, D.C. - In Law360, Edgeworth Senior Vice President Matthew Milner opined on the reliability of structured data in litigation, writing “Structured data is frequently the foundation of expert analysis in litigation for a variety of damages and liability issues. Often, statistical analyses prepared by experts are based on structured data from the parties to the litigation.

Washington, D.C. - In Law360, Edgeworth Expert Dr. Jesse David writes, “Recent Federal Circuit decisions regarding reasonable royalties have highlighted the importance of a rigorous, economics-based analysis of a patent’s contribution to the overall value of the accused product.